Table 1.
Laboratory Data on Admission (1).
| WBC | 7,500 | /μL | T-Bil | 0.7 | mg/dL | HDL-C | 60 | mg/dL |
| RBC | 405×104 | /μL | D-Bil | 0.5 | mg/dL | LDL-C | 125 | mg/dL |
| Hb | 12.9 | g/dL | AST | 66 | U/L | Trig | 160 | mg/dL |
| Hct | 38.9 | % | ALT | 84 | U/L | |||
| Pl | 34.5×104 | /μL | Al-P | 1,557 | U/L | HBsAg | (-) | |
| γ-GTP | 402 | U/L | HBcAb | (-) | ||||
| Neut | 54.9 | % | LDH | 181 | U/L | IgM HBcAb | (-) | |
| Baso | 2.1 | % | CK | 55 | U/L | HCVAb | (-) | |
| Eosino | 9.3 | % | T-protein | 7.8 | g/dL | IgA HEV Ab | (-) | |
| Mono | 3.0 | % | Albumin | 5.0 | g/dL | IgM EBV Ab | (-) | |
| Lymph | 30.7 | % | BUN | 16.6 | mg/dL | IgM CMV Ab | (-) | |
| Crea | 0.75 | mg/dL | ||||||
| PT | 105 | % | BS | 102 | mg/dL | CEA | 5.0 | ng/mL/L |
| HbA1c | 5.5 | % | CA19-9 | 0.5 | mU/L |
γ-GTP: γ-glutamyltransferase, Al-P: alkaline phosphatase, ALT: alanine aminotransferase, AST: aspartate aminotransferase, Baso: basophils, BS: blood sugar, BUN: blood urea nitrogen, CA19-9: carbohydrate antigen 19-9, CEA: carcinoembryonic antigen, CK: creatine kinase, CMV Ab: cytomegalovirus antibody, Crea: creatinine, D-Bil: direct bilirubin, Eosino: eosinophils, Hb: hemoglobin, EBV Ab: Epstein-Barr virus antibody, Hct: hematocrit, HbA1c: glycated hemoglobin, HDL-C: high density lipoprotein cholesterol, HBcAb: hepatitis B core antibody, HBsAg: hepatitis B surface antigen, HCV Ab: hepatitis C virus antibody, HEV Ab: hepatitis E virus antibody, IgA: immunoglobulin A, IgG: immunoglobulin G, IgM: immunoglobulin M, Lymph: lymphocytes, LDH: lactate dehydrogenase, LDL-C: low density lipoprotein cholesterol, Mono: monocytes, Neut: neutrophils, Pl: platelet count, PT: prothrombin time, RBC: red blood cell count, T-Bil: total bilirubin, Trig: triglycerides, T-protein: total protein, WBC: white blood cell count